Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
Cancer Cell2016Vol. 29(5), pp. 653–668
Citations Over TimeTop 1% of 2016 papers
Le Qu, Jin Ding, Cheng Chen, Zhenjie Wu, Bing Liu, Yi Gao, Wei Chen, Feng Liu, Wen Sun, Xiaofeng Li, Xue Wang, Yue Wang, Zhenyu Xu, Li Gao, Qing Yang, Bin Xu, Yaoming Li, Ziyu Fang, Zhipeng Xu, Yi Bao, Deng-Shuang Wu, Miao Xiong, Haiyang Sun, Yinghao Sun, Hongyang Wang, Linhui Wang
Related Papers
- → Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma—Results of the REchallenge with SUnitinib in MEtastatic RCC (RESUME) Study(2016)36 cited
- → Improvement of Psoriasis During Sunitinib Therapy for Renal Cell Carcinoma(2010)33 cited
- → Ischaemic stroke in a patient on sunitinib: Figure 1(2010)6 cited
- → Sunitinib in Patients with Metastatic Renal Cell Carcinoma with Favorable Risk: Be Aware of PD-L1 Expression(2024)3 cited
- → Sunitinib Versus Interferon Alfa in Metastatic Renal Cell Carcinoma(2021)3 cited